XML 67 R50.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Company's Stock Options Outstanding
The following tables presents information regarding the activity during 2025, 2024 and 2023 related to the Company’s share grant to non-employee directors:
For the year ended December 31, Date of grantFair market value of common shareCommon shares grantedNumber of non-employee directorsCommon shares granted per non-employee directorGrant expense
2025June 2, 2025$40.63 8,307 9923 $337,500 
2024May 31, 2024$31.55 15,457 131,189 $487,500 
2023June 1, 2023$30.69 17,094 141,221 $525,000 
Stock option activity and related information is presented below as of and for the periods indicated:
Options Outstanding
Number of
Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual Term
(years)
Aggregate
Intrinsic
Value
(thousands)
Balance at January 1, 2023— $— 
Replacement options issued in conjunction with acquisition of GrandSouth542,345 $20.14 
Exercised during the period(236,760)$19.09 
Forfeited or expired during the period— $— 
Balance at December 31, 2023305,585 $20.95 
Exercised during the period(194,884)21.70 
Forfeited or expired during the period— — 
Balance at December 31, 2024110,701 19.63 
Exercised during the period(91,483)19.79 
Forfeited or expired during the period— — 
Outstanding at December 31, 202519,218 $18.89 4.16$613 
Exercisable at December 31, 202519,218 $18.89 4.16$613 
Schedule of Outstanding Restricted Stock
The following table presents information regarding the activity during 2023, 2024, and 2025 related to the Company’s outstanding restricted stock awards:
 Long-Term Restricted Stock Awards
SharesWeighted-Average
Grant-Date Fair Value
Nonvested at January 1, 2023223,012 $36.14 
Granted during the period143,380 37.08 
Vested during the period(74,310)29.43 
Forfeited or expired during the period(791)37.88 
Nonvested at December 31, 2023291,291 36.14 
Granted during the period67,900 38.14 
Vested during the period(119,906)41.72 
Forfeited or expired during the period(2,334)42.84 
Nonvested at December 31, 2024236,951 36.43 
Granted during the period91,723 42.06 
Vested during the period(116,726)37.81 
Forfeited or expired during the period(5,324)41.40 
Nonvested at December 31, 2025206,624 $38.08 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following table illustrates the assumptions for the Black-Scholes model used in determining the fair value of options granted during the year ended December 31, 2023:
Fair value per option, weighted average$24.85 
Expected life (years)
1.4 - 4.7
Expected stock price volatility, weighted average46.39 %
Expected dividend yield2.05 %
Risk-free interest rate, weighted average4.18 %
Expected forfeiture rate0.00 %